Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (RESTORE)

This study has been completed.
Sponsor:
Collaborator:
Profil GmbH, Neuss, Germany
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT00931372
First received: June 30, 2009
Last updated: February 22, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)